Circassia Pharmaceuticals - Company & Market Research Reports

Circassia is a pharmaceutical company that innovates products for respiratory diseases. Circassia was established in 2006 in Morrisville, U.S. In March 2014 they completed an initial public offering on the London Stock Exchange.The product Tudorza is marketed by Circassia which is a product used to treat COPD chronic obstructive pulmonary disease.Circassia collaborates with Astra Zeneca which helps them promote Tudorza and it gives them rights to Duaklir® which has increased their sales majorly. Also in 2015, they completed acquisitions with Aerocrine and Prosonix which helps them to commercialize their products and broaden their pipelines.

From
From
From
From
Allergic Asthma - Pipeline Review, H2 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H2 2016

  • Drug Pipelines
  • 181 Pages
From
From
Allergic Asthma - Pipeline Review, H1 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H1 2016

  • Drug Pipelines
  • 182 Pages
From
From
From
From
From
From
From
Birch Pollen Allergy - Pipeline Insight, 2018 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
Ragweed Allergy - Pipeline Review, H2 2016 - Product Thumbnail Image

Ragweed Allergy - Pipeline Review, H2 2016

  • Drug Pipelines
  • 37 Pages
From
Ragweed Allergy - Pipeline Review, H1 2016 - Product Thumbnail Image

Ragweed Allergy - Pipeline Review, H1 2016

  • Drug Pipelines
  • 41 Pages
From
Pollen Allergy - Pipeline Review, H2 2015 - Product Thumbnail Image

Pollen Allergy - Pipeline Review, H2 2015

  • Drug Pipelines
  • 106 Pages
From
Loading Indicator
adroll